CCA Industries, Inc. (OTCID:CAWW)

WEB NEWS

Thursday, March 5, 2026

Research

Cca Industries, Inc. (OOTC:CAWW) ($0.51; $3.4M market cap) announced FY 2025 results:

  • Q4 2025 sales of $1.3 million vs. $1.6 million in the prior year
  • Q4 2025 EPS: loss of $(0.09) vs. loss of $(0.14) in the prior year
  • FY 2025 sales of $5,922,607 vs. $7,737,598 in the prior year
  • FY 2025 EPS: loss of $(0.10) vs. $(0.24) in the prior year

Management Commentary:

"Our 2025 results demonstrate meaningful progress. While revenue was lower than the prior year, much of the decline was intentional, reflecting our strategic decision to exit unprofitable products and focus on higher-margin opportunities. These actions have strengthened our resilience and diversified our business across both brick-and-mortar and online channels. Our contribution margin grew over 46% year-over-year, reflecting disciplined, strategic decisions, some of which were difficult but necessary. During 2025, supply-chain disruptions affected our two top-selling products and a key skincare ingredient, affecting our topline, but with new suppliers and increased inventory, stock levels returned to normal by the fourth quarter of fiscal 2025."

"At the end of January 2026, we sold the Lobe Miracle brand to generate capital to support our strategic focus on growing our flagship Plus White brand. This divestiture allows us to concentrate resources and accelerate investment in Plus White. In just the first month post-transaction, we are seeing over 50% top-line growth in Plus White compared to the prior year. We believe there is significant opportunity to expand our market share within the $8 billion teeth whitening category, and early indicators are promising."

"Our primary goal remains delivering profitable top-line growth, strengthening our cost structure, and positioning CCA for sustainable, long-term success. By balancing brick-and-mortar retail with online channels, we aim to reduce volatility and enhance long-term shareholder value.”

Our Quick Take:

CAWW is still in turnaround mode. They discontinued unprofitable products, which should increase their margins, and the recent divestment of their Lobe Miracle Brand allows them to focus on their growing Plus White brand, which has been growing at more than 50%.

Furthermore, CAWW hasn’t really been successful with its turnaround efforts as it has not been consistent with revenue growth and profitability yet. They kind of keep changing their plan because nothing has stuck. That’s minorly concerning, but not enough to change our desire to track the company.

CCA Industries, Inc. manufactures and distributes health and beauty products, including oral care, skincare, nail treatments, medicated gels, depilatories, and perfumes, sold under various brand names through retail chains, distributors, and online channels.


Monday, March 3, 2025

Research

Cca Industries  (OTC:CAWW) ($0.60; $4.5M market cap) announced Q4 2024 results

  • Sales of $1.6 million vs $2.1 million in the prior year
  • Non-GAAP net loss of $0.07 vs a net loss of $0.24 in the prior year

 "I will start with the most important part first.  As we wrap up the first quarter of 2025, we expect EBITDA to be profitable for the quarter.  This is a substantial jump from the first quarter of 2024 where we lost close to $300K, and we expect that trend to continue in the quarters to come.  As we said throughout 2024, it was a year of transition from a 100% brick-and-mortar retail company to a hybrid company through the growth of our online channels." Dominello continued, "We made many moves in 2024 that were hard decisions to make and others that were a bit easier, but we felt that all of them were the right ones for the future of CCA.  The Company has made some significant restructuring changes to the business, including consolidating the three warehouses we were using into one new warehouse, which lowers our operating costs.  We have already seen the results of that change in the first two months of fiscal 2025, with much lower warehouse and shipping costs, and cost of goods that decreased by approximately 5%.  As I always say, we still face challenges, but we are still clear-eyed on what we need to do and where we are going. I look forward to sharing Q1 results in the very near future."

CCA Industries, Inc. manufactures and distributes health and beauty aid products in the United States and internationally.


Wednesday, October 16, 2024

Research

Cca Industries  (OTC:CAWW) ($0.83; $5.6M market cap) announced Q3 2024 results

  • Sales of $1.7 million vs $2.8 million in the prior year
  • Net loss of $0.06 vs a net loss of $0.06

Results via 10-Q only, we await the company’s press release for more color from management. Recall in the last release, the company mentioned 

“Neutein, our brain health supplement launched at CVS in the second quarter of fiscal 2024, giving us pipeline orders in Q3.  While we are encouraged with our achievements to date, we are still a work in progress.  We have developed plans to grow both top and bottom line and are executing them during Q3, but the benefits will likely not be felt until Q4.  These additional changes to increase our profitability will be announced later in the fourth quarter."


Tuesday, July 16, 2024

Research

Cca Industries  (OTC:CAWW) ($0.82; $5.6M market cap) announced Q2 2024 results

  • Sales of $2.2 million vs $2.9 million in the prior year

  • Net loss of $0.00 vs a net loss of $0.02

“The EBITDA profit for the second quarter of fiscal 2024, though small, shows the beginning of our turn-around.  As a reminder, we sold the Bikini Zone brand in the fourth quarter of fiscal 2023 which had sales of $3.2 million in the first half of fiscal 2023.  Working to overcome that loss of revenue has been a focus, and our other brands have been increasing to fill the gap.  Lobe Miracle, our ear protection brand, had increased gross sales by 31.6% year over year.  Our Sudden Change skincare brand gross sales were up 20.3% year over year, and Neutein, our brain health supplement launched at CVS in the second quarter of fiscal 2024, giving us pipeline orders in Q3.  While we are encouraged with our achievements to date, we are still a work in progress.  We have developed plans to grow both top and bottom line and are executing them during Q3, but the benefits will likely not be felt until Q4.  These additional changes to increase our profitability will be announced later in the fourth quarter." 

Seems the turnaround story is progressing, we look forward to seeing what type of growth management sees come Q4. 



Market Data powered by QuoteMedia. Terms of Use